PDB Short entry for 1PLN
HEADER    MEMBRANE PROTEIN                        06-AUG-98   1PLN              
TITLE     MODEL OF THE PENTAMERIC TRANSMEMBRANE DOMAIN OF                       
TITLE    2 PHOSPHOLAMBAN, A PUTATIVE CARDIAC ION CHANNEL                        
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: PROTEIN (CARDIAC PHOSPHOLAMBAN);                           
COMPND   3 CHAIN: A, B, C, D, E;                                                
COMPND   4 FRAGMENT: PUTATIVE MEMBRANE SPANNING DOMAIN 35-52;                   
COMPND   5 SYNONYM: PLB(35-52)                                                  
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE   3 ORGANISM_COMMON: HUMAN;                                              
SOURCE   4 OTHER_DETAILS: SARCOPLASMIC RETICULUM                                
KEYWDS    ION CHANNEL, ATPASE REGULATOR, PHOSPHORYLATION, HELIX BUNDLE          
EXPDTA    THEORETICAL MODEL                                                     
AUTHOR    P.HERZYK,R.E.HUBBARD                                                  
REVDAT   2   29-DEC-99 1PLN    4       HEADER COMPND REMARK JRNL                
REVDAT   2 2                   4       ATOM   SOURCE SEQRES                     
REVDAT   1   12-AUG-98 1PLN    0                                                
JRNL        AUTH   P.HERZYK,R.E.HUBBARD                                         
JRNL        TITL   USING EXPERIMENTAL INFORMATION TO PRODUCE A MODEL            
JRNL        TITL 2 OF THE TRANSMEMBRANE DOMAIN OF THE ION CHANNEL               
JRNL        TITL 3 PHOSPHOLAMBAN.                                               
JRNL        REF    BIOPHYS.J.                    V.  74  1203 1998              
JRNL        REFN   ASTM BIOJAU  US ISSN 0006-3495                               
REMARK   1                                                                      
REMARK   1 REFERENCE 1                                                          
REMARK   1  AUTH   P.HERZYK,R.E.HUBBARD                                         
REMARK   1  TITL   AUTOMATED METHOD FOR MODELING SEVEN-HELIX                    
REMARK   1  TITL 2 TRANSMEMBRANE RECEPTORS FROM EXPERIMENTAL DATA               
REMARK   1  REF    BIOPHYS.J.                    V.  69  2419 1995              
REMARK   1  REFN   ASTM BIOJAU  US ISSN 0006-3495                               
REMARK   2                                                                      
REMARK   2 RESOLUTION. NOT APPLICABLE.                                          
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : NULL                                                 
REMARK   3   AUTHORS     : NULL                                                 
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: REFINEMENT IS CARRIED OUT AS              
REMARK   3  DESCRIBED IN THE JRNL CITATION ABOVE, EXCEPT THAT (1) DIHEDRAL      
REMARK   3  ANGLE POTENTIAL IS ADDED FROM THE ANNEALING STAGE ONWARDS, (2)      
REMARK   3  THE FINAL UNCONSTRAINED MINIMISATION IS CARRIED OUT USING           
REMARK   3  UNMODIFIED TOPH19 - POLOGY AND PARAM19 PARAMETER SETS.              
REMARK   4                                                                      
REMARK   4 1PLN COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998                       
REMARK   6                                                                      
REMARK   6 THE COORDINATES IN THIS ENTRY REPRESENT A THEORETICAL MODEL          
REMARK   6  STRUCTURE. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT *             
REMARK   6 CRYST1* AND *SCALE* RECORDS BE INCLUDED, BUT THE VALUES ON           
REMARK   6 THESE RECORDS ARE MEANINGLESS.                                       
REMARK   7                                                                      
REMARK   7 THE SEQUENCE MODELLED IS THAT OF THE PUTATIVE TRANSMEMBRANE          
REMARK   7  REGION AND THEREFORE BEGINS AT RESIDUE 35 AND ENDS AT               
REMARK   7  RESIDUE 52.                                                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-SEP-1999.                
REMARK 100 THE RCSB ID CODE IS RCSB008375.                                      
REMARK 220                                                                      
REMARK 220 EXPERIMENTAL DETAILS                                                 
REMARK 220  EXPERIMENT TYPE                : THEORETICAL MODELLING              
REMARK 220                                                                      
REMARK 220 REMARK: MODELLING PROGRAM: PANDA, X-PLOR MODELLING EXPERIMENT:       
REMARK 220         AN ATOMIC MODEL OF THE TRANSMEMBRANE (TM) DOMAIN OF THE      
REMARK 220         PHOSPHOLAMBAN PENTAMER HAS BEEN GENERATED BY A               
REMARK 220         COMPUTATIONAL METHOD THAT USES THE EXPERIMENTALLY            
REMARK 220         MEASURED EFFECTS OF SYSTEMATIC SINGLE-SITE MUTATIONS         
REMARK 220         UPON THE OLIGOMERIZATION (SIMMERMAN ET AL., 1996) AS         
REMARK 220         GUIDING FORCES IN THE MODELLING PROCEDURE. THIS METHOD       
REMARK 220         MAKES THE ASSUMPTION THAT (1) THE PHOSPHOLAMBAN TM           
REMARK 220         DOMAIN IS A PARALLEL FIVE-HELIX BUNDLE, AND (2)              
REMARK 220         NONDISRUPTIVE MUTATION POSITIONS ARE LIPID EXPOSED,          
REMARK 220         WHEREAS (3) DISRUPTIVE OR PARTIALLY DISRUPTIVE MUTATIONS     
REMARK 220         ARE NOT. IN THE FIRST STAGE, A SIMPLIFIED TEMPLATE           
REMARK 220         REPRESENTING A 3-D ARRANGEMENT OF FIVE RIGID, IDEALIZED      
REMARK 220         HELICES IS GENERATED. THIS PROCESS IS PREDOMINANTLY          
REMARK 220         GUIDED BY EXPERIMENTAL INFORMATION AND IS ACHIEVED BY        
REMARK 220         MONTE CARLO SIMULATED ANNEALING (MCSA) OPTIMIZATION OF A     
REMARK 220         FUNCTION PENALIZING VIOLATIONS OF STRUCTURAL RESTRAINTS      
REMARK 220         DERIVED FROM THE INTERPRETATION OF THE MUTAGENESIS DATA      
REMARK 220         (REFERENCE 1). THIS SIMPLIFIED TEMPLATE STRUCTURE IS         
REMARK 220         THEN REFINED INTO A FULL-ATOM REPRESENTATION AND ITS         
REMARK 220         GEOMETRY OPTIMIZED IN A SERIES OF MOLECULAR DYNAMICS         
REMARK 220         SIMULATED ANNEALING (MDSA) CALCULATIONS. THUS THE            
REMARK 220         REFINEMENT STEP GENERATES THE MOST PROBABLE FULL-ATOM        
REMARK 220         PROTEIN STRUCTURE THAT CORRESPONDS TO THE EXPERIMENTALLY     
REMARK 220         DRIVEN SIMPLIFIED TEMPLATE.                                  
REMARK 225                                                                      
REMARK 225 THEORETICAL MODEL                                                    
REMARK 225 THE COORDINATES IN THIS ENTRY REPRESENT A MODEL STRUCTURE.           
REMARK 225 PROTEIN DATA BANK CONVENTIONS REQUIRE THAT CRYST1 AND                
REMARK 225 SCALE RECORDS BE INCLUDED, BUT THE VALUES ON THESE                   
REMARK 225 RECORDS ARE MEANINGLESS.                                             
REMARK 650                                                                      
REMARK 650 HELIX                                                                
REMARK 650 DETERMINATION METHOD: AUTHOR-DETERMINED                              
DBREF  1PLN A   35    52  UNP    P26678   PPLA_HUMAN      35     52             
DBREF  1PLN B   35    52  UNP    P26678   PPLA_HUMAN      35     52             
DBREF  1PLN C   35    52  UNP    P26678   PPLA_HUMAN      35     52             
DBREF  1PLN D   35    52  UNP    P26678   PPLA_HUMAN      35     52             
DBREF  1PLN E   35    52  UNP    P26678   PPLA_HUMAN      35     52             
SEQRES   1 A   18  PHE CYS LEU ILE LEU ILE CYS LEU LEU LEU ILE CYS ILE          
SEQRES   2 A   18  ILE VAL MET LEU LEU                                          
SEQRES   1 B   18  PHE CYS LEU ILE LEU ILE CYS LEU LEU LEU ILE CYS ILE          
SEQRES   2 B   18  ILE VAL MET LEU LEU                                          
SEQRES   1 C   18  PHE CYS LEU ILE LEU ILE CYS LEU LEU LEU ILE CYS ILE          
SEQRES   2 C   18  ILE VAL MET LEU LEU                                          
SEQRES   1 D   18  PHE CYS LEU ILE LEU ILE CYS LEU LEU LEU ILE CYS ILE          
SEQRES   2 D   18  ILE VAL MET LEU LEU                                          
SEQRES   1 E   18  PHE CYS LEU ILE LEU ILE CYS LEU LEU LEU ILE CYS ILE          
SEQRES   2 E   18  ILE VAL MET LEU LEU                                          
HELIX    1   A PHE A   35  LEU A   52  1                                  18    
HELIX    2   B PHE B   35  LEU B   52  1                                  18    
HELIX    3   C PHE C   35  LEU C   52  1                                  18    
HELIX    4   D PHE D   35  LEU D   52  1                                  18    
HELIX    5   E PHE E   35  LEU E   52  1                                  18    
CRYST1    1.000    1.000    1.000  90.00  90.00  90.00 P 1           1          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      1.000000  0.000000  0.000000        0.00000                         
SCALE2      0.000000  1.000000  0.000000        0.00000                         
SCALE3      0.000000  0.000000  1.000000        0.00000